These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 3488309)
1. Influence of three modes of administration on the penetration of latamoxef into interstitial fluid and fibrin clots and its in-vivo activity against Haemophilus influenzae. Bergeron MG; Simard P J Antimicrob Chemother; 1986 Jun; 17(6):775-84. PubMed ID: 3488309 [TBL] [Abstract][Full Text] [Related]
2. Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae. Lavoie GY; Bergeron MG Antimicrob Agents Chemother; 1985 Sep; 28(3):404-12. PubMed ID: 3878128 [TBL] [Abstract][Full Text] [Related]
3. [Dying kinetics of H. influenzae in fibrin clots under the influence of various antibiotics]. Guggenbichler JP; Allerberger F Wien Med Wochenschr; 1991; 141(21):501-4. PubMed ID: 1781178 [TBL] [Abstract][Full Text] [Related]
4. Comparative activities of moxalactam (LY 127935) a new semisynthetic 1-oxa-beta lactam antibiotic with 7 other antibiotics against type b Haemophilus influenzae. Chu ML; Harms JL; Liu C Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Sep; 14(3):146-55. PubMed ID: 6456875 [TBL] [Abstract][Full Text] [Related]
5. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations. Kaplan SL; Mason EO; Kvernland SJ; Calaway EL; Feigin RD Rev Infect Dis; 1982; 4 Suppl():S597-602. PubMed ID: 6218570 [TBL] [Abstract][Full Text] [Related]
6. Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis. Contrepois A; Vallois JM; Garaud JJ; Pangon B; Mohler J; Meulemans A; Carbon C J Antimicrob Chemother; 1986 Feb; 17(2):227-37. PubMed ID: 3516963 [TBL] [Abstract][Full Text] [Related]
7. [Experimental and clinical evaluation latamoxef in newborn and premature infants]. Toyonaga Y; Kurosu Y; Sugita M; Kitagawa M; Hori M Jpn J Antibiot; 1983 Sep; 36(9):2322-35. PubMed ID: 6655851 [TBL] [Abstract][Full Text] [Related]
8. Penetration of cefixime into fibrin clots and in vivo efficacy against Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus. Bergeron MG; Turcotte A Antimicrob Agents Chemother; 1986 Dec; 30(6):913-6. PubMed ID: 3545070 [TBL] [Abstract][Full Text] [Related]
9. Impact of single dose as compared to three dose prophylaxis with latamoxef (moxalactam) on the colonic microflora in patients undergoing colorectal surgery. Kager L; Malmborg AS; Nord CE; Sjöstedt S J Antimicrob Chemother; 1984 Aug; 14(2):171-7. PubMed ID: 6501124 [TBL] [Abstract][Full Text] [Related]
10. Differential increased survival of staphylococci and limited ultrastructural changes in the core of infected fibrin clots after daptomycin administration. Michiels MJ; Bergeron MG Antimicrob Agents Chemother; 1996 Jan; 40(1):203-11. PubMed ID: 8787906 [TBL] [Abstract][Full Text] [Related]
11. Comparative penetration of latamoxef (moxalactam) and cefazolin into human knee following simultaneous administration. Hume AL; Polk R; Kline B; Cardea J J Antimicrob Chemother; 1983 Dec; 12(6):623-7. PubMed ID: 6662840 [TBL] [Abstract][Full Text] [Related]
12. What preclinical data are needed to justify once-daily therapy? Bergeron MG J Clin Pharmacol; 1992 Aug; 32(8):698-705. PubMed ID: 1487558 [TBL] [Abstract][Full Text] [Related]
13. Biliary excretion of latamoxef and N-methyltetrazolethiol in humans and rats. Uchida K; Konishi M; Akiyoshi T; Igimi H; Asakawa S J Pharmacobiodyn; 1985 Nov; 8(11):981-8. PubMed ID: 4093852 [TBL] [Abstract][Full Text] [Related]
14. [Concentration level of latamoxef sodium (LMOX) in prostatic tissue]. Takao M; Matsuzaki S; Ao T; Nagakura K; Fujioka T; Hata M; Nakamura H; Hayakawa M Hinyokika Kiyo; 1985 Mar; 31(3):539-43. PubMed ID: 2411116 [TBL] [Abstract][Full Text] [Related]
15. Penetration of cefamandole, cephalothin, and desacetylcephalothin into fibrin clots. Bergeron MG; Nguyen BM; Trottier S; Gauvreau L Antimicrob Agents Chemother; 1977 Dec; 12(6):682-7. PubMed ID: 931366 [TBL] [Abstract][Full Text] [Related]
16. The penetration of amphotericin B from an Intralipid formulation into fibrin loci in a rabbit model of candidiasis. Bouley M; Tod M; Chavanet P; Petitjean O Biopharm Drug Dispos; 1994 Aug; 15(6):485-92. PubMed ID: 7993986 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the bactericidal curves of beta-lactam and aminoglycoside combinations at the concentrations obtained in the cerebrospinal fluid in Haemophilus influenzae meningitis]. Bingen E; Lambert-Zechovsky N; Mariani P; Lemer G; Sauzeau C; Aujard Y; Mathieu H Presse Med; 1987 Dec; 16(43):2156-60. PubMed ID: 2963303 [TBL] [Abstract][Full Text] [Related]
18. [A comparison of the penetration characteristics of latamoxef and cephalothin into the right atrial appendage and pericardial fluid of adult patients undergoing open-heart surgery]. Sato Y; Kanazawa H; Okazaki H; Kosuge T; Imaizumi K; Eguchi S Jpn J Antibiot; 1984 Apr; 37(4):671-9. PubMed ID: 6471383 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of cefotaxime, ceftizoxime, cefmenoxime, and latamoxef in comparison with other beta-lactam antibiotics against recent clinical isolates of Haemophilus influenzae and Haemophilus parainfluenzae. Kawakami Y; Okimura Y; Horiuchi N; Kanai M Microbiol Immunol; 1982; 26(7):617-21. PubMed ID: 6290854 [No Abstract] [Full Text] [Related]